# Photodynamic Therapy in Occult-Only Lesions (POOL)

> **NCT00135837** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 202 (—)

## Conditions studied

- Age-Related Macular Degeneration

## Interventions

- **DRUG:** Verteporfin for injection

## Key facts

- **NCT ID:** NCT00135837
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 202 (—)
- **Last updated:** 2006-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00135837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00135837, "Photodynamic Therapy in Occult-Only Lesions (POOL)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00135837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*